Vedanta may test Rs 336, Sun Pharma Rs 600: Hemant Thukral

Hemant Thukral of Aditya Birla Money told CNBC-TV18, "Two sectors stocks I will recommend today. One is metals and in that we have chosen Vedanta. 61 percent positions have been rolled till yesterday and if you see its averages, t-1 is 45. So we are expecting it to cross 80 percent rollovers which Vedanta has not done from last six months."

"Importantly, Vedanta has closed yesterday above Rs 320 which was acting as a slightly stiff resistance on technical grounds. So we feel that one should keep a stoploss of Rs 322 and we expect a target of Rs 336 as the first target."

"Second sector is pharmaceutical and in that we have seen very good rollovers happening. In fact, Sun Pharmaceutical has done 76 percent, so we expect it to do like last month, it had done 90, and we are expecting it to cross 90-91 percent rollovers. However, this time the rollovers are happening when Sun Pharmaceutical has given a clear breakout on charts yesterday."

"We expect this momentum to continue. First target should be Rs 597-600 zone and we will keep a stoploss of Rs 565. So we are recommending two trades, one in Vedanta and one in Sun Pharmaceutical," he said.